Shockwave Medical Inc. (NASDAQ: SWAV)’s stock price has soared by 0.10 in relation to previous closing price of 328.54. Nevertheless, the company has seen a gain of 0.42% in its stock price over the last five trading days. Zacks Investment Research reported 2024-04-22 that Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Is It Worth Investing in Shockwave Medical Inc. (NASDAQ: SWAV) Right Now?
Shockwave Medical Inc. (NASDAQ: SWAV) has a price-to-earnings ratio that is above its average at 85.18x. The stock has a 36-month beta value of 0.88. Opinions on the stock are mixed, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for SWAV is 36.72M, and at present, short sellers hold a 5.53% of that float. On April 25, 2024, the average trading volume of SWAV was 1.04M shares.
SWAV’s Market Performance
SWAV stock saw an increase of 0.42% in the past week, with a monthly gain of 14.50% and a quarterly increase of 46.49%. The volatility ratio for the week is 0.42%, and the volatility levels for the last 30 days are 1.73% for Shockwave Medical Inc. (SWAV). The simple moving average for the past 20 days is 1.10% for SWAV’s stock, with a 42.25% simple moving average for the past 200 days.
Analysts’ Opinion of SWAV
CL King, on the other hand, stated in their research note that they expect to see SWAV reach a price target of $368. The rating they have provided for SWAV stocks is “Buy” according to the report published on March 27th, 2024.
UBS gave a rating of “Neutral” to SWAV, setting the target price at $218 in the report published on September 29th of the previous year.
SWAV Trading at 14.47% from the 50-Day Moving Average
After a stumble in the market that brought SWAV to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -0.82% of loss for the given period.
Volatility was left at 1.73%, however, over the last 30 days, the volatility rate increased by 0.42%, as shares surge +4.05% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +39.56% upper at present.
During the last 5 trading sessions, SWAV rose by +0.42%, which changed the moving average for the period of 200-days by +18.50% in comparison to the 20-day moving average, which settled at $325.94. In addition, Shockwave Medical Inc. saw 72.58% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at SWAV starting from Zacharias Isaac, who sale 4,000 shares at the price of $287.67 back on Mar 26 ’24. After this action, Zacharias Isaac now owns 56,818 shares of Shockwave Medical Inc., valued at $1,150,680 using the latest closing price.
FRANCIS LAURA, the Director of Shockwave Medical Inc., sale 1,500 shares at $300.00 during a trade that took place back on Mar 26 ’24, which means that FRANCIS LAURA is holding 3,551 shares at $450,000 based on the most recent closing price.
Stock Fundamentals for SWAV
Current profitability levels for the company are sitting at:
- 0.22 for the present operating margin
- 0.87 for the gross margin
The net margin for Shockwave Medical Inc. stands at 0.2. The total capital return value is set at 0.11. Equity return is now at value 24.96, with 13.24 for asset returns.
Based on Shockwave Medical Inc. (SWAV), the company’s capital structure generated 0.52 points at debt to capital in total, while cash flow to debt ratio is standing at 0.27. The debt to equity ratio resting at 1.1. The interest coverage ratio of the stock is 23.23.
Currently, EBITDA for the company is 176.35 million with net debt to EBITDA at 2.59. When we switch over and look at the enterprise to sales, we see a ratio of 17.49. The receivables turnover for the company is 6.37for trailing twelve months and the total asset turnover is 0.47. The liquidity ratio also appears to be rather interesting for investors as it stands at 11.76.
Conclusion
To sum up, Shockwave Medical Inc. (SWAV) has seen a better performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
